Cushing's Syndrome Due to Pharmacological Interaction in a Cystic Fibrosis Patient
September 2002
in “
Acta pædiatrica
”
Cushing's syndrome iatrogenic itraconazole budesonide striae moon-face increased facial hair growth mood swings headaches weight gain irregular menstruation increased insulin requirement plasma cortisol adrenocorticotropin cytochrome P450 enzymes CYP3A isoforms adrenal insufficiency Cushing's syndrome moon-face increased facial hair growth mood swings headaches weight gain irregular menstruation increased insulin requirement adrenal insufficiency
Studysummary In this study, a patient with cystic fibrosis developed iatrogenic Cushing's syndrome due to impaired clearance of budesonide from concurrent itraconazole use, highlighting the need for regular monitoring in such combination therapies.
Automatically generated from the study's abstract, not written by a person, and not a review of the full paper. Not medical advice or a treatment recommendation. Read the original study, and consult a qualified healthcare professional before changing treatment. Full disclaimer
Read the full study on onlinelibrary.wiley.com →